drugset
drugset / Trial / NCT01542450

Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes

NCT01542450 ↗

Phase 1 Completed 23 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Japan. The aim for this trial is to investigate the pharmacodynamics and pharmacokinetics of insulin detemir and insulin NPH in Japanese subjects with type 1 diabetes mellitus.

Timeline

Start
2002-08
Primary completion
2003-02
Completion
2003-02

Publications

  • Results Irie S, Matsumura Y, Hirano K. Pharmacokinetics and Pharmacodynamics of Single Dose Insulin Detemir, Long-acting soluble insulin analogue compared to NPH insulin in Patients with type 1 Diabetes Mellitus. Journal of Clinical Ther. and Med. 2007; 5 (23): 349-356

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin NPH Protein / enzyme biologic 0.3 iu/kg Subcutaneous
Subject insulin detemir Protein / enzyme biologic 0.3 iu/kg Subcutaneous

Indications

type 1 diabetes mellitus